HomeINKT • NASDAQ
Mink Therapeutics Inc
add
$7.54
2.59%
After Hours:(4.91%)-0.37
$7.17
Closed: May 16, 4:02:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.50M | -54.50% |
Net income | -2.46M | 54.88% |
Net profit margin | — | — |
Earnings per share | -0.62 | 58.67% |
EBITDA | -2.45M | 55.04% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.58M | 35.93% |
Total assets | 5.72M | 25.67% |
Total liabilities | 25.31M | 11.94% |
Total equity | -19.59M | — |
Shares outstanding | 3.97M | — |
Price to book | -1.49 | — |
Return on assets | -95.55% | — |
Return on capital | 45.33% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.46M | 54.88% |
Cash from operations | -1.73M | 43.09% |
Cash from investing | — | — |
Cash from financing | -3.00 | -50.00% |
Net change in cash | -1.75M | 42.24% |
Free cash flow | -1.72M | -20.20% |
Previous close
$7.35
Day range
$7.18 - $7.54
Year range
$4.56 - $13.79
Market cap
29.91M USD
Avg Volume
4.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Website
Employees
23
